Jupiter Life Line Hospitals IPO Review

Jupiter Life Line Hospitals IPO Assessment: Jupiter Life Line Hospitals is developing with its Preliminary Public Providing. The IPO will open for subscription on September 6, 2023, and shut on September 8, 2023.

On this article, we are going to have a look at Jupiter Life Line Hospitals IPO Assessment 2023 and analyze its financials, strengths, weaknesses, GMP & extra. Maintain studying to search out out! 

Jupiter Life Line Hospitals IPO – About The Firm

Jupiter Life Line Hospitals Restricted, included in 2007, is a multi-specialty tertiary and quaternary healthcare supplier within the Mumbai Metropolitan Space (MMR) and India’s western area.

As of FY23, it was working as a company quaternary care healthcare service supplier within the western areas of India, with three hospitals underneath the “Jupiter” model in Thane, Pune, and Indore, with a complete operational mattress capability of 1194 beds and 1,306 docs together with specialists, physicians, and surgeons.

In accordance with the CRISIL Report, the corporate’s Thane and Indore hospitals are among the many few in India’s western area to supply neuro-rehabilitation remedies by way of a specialised robotic and computer-assisted neuro-rehabilitation centre. Moreover, it operates certainly one of Thane’s few multi-organ transplant centres. 

In Fiscal 2023, the corporate’s inpatient and outpatient income is distributed throughout hospitals, with Thane, Pune, and Indore hospitals accounting for 54.18%, 34.03%, and 11.79% of income from operations, respectively.

Jupiter Life Line Hospitals IPO Assessment – Trade Overview

West India’s healthcare market is predicted to extend at a 14%-16% CAGR from ₹1.05-1.15 trillion in FY22 to ₹2.15-2.25 trillion in FY27. Decrease penetration of chained hospitals, growing common income per occupied mattress figures of personal gamers within the area, the area’s excessive inhabitants density, and growing penetration of medical insurance within the area are anticipated to drive the expansion of India’s western healthcare supply market. The Western area’s improved entry to medical insurance can even contribute to the growth of the healthcare supply market.

Jupiter Life Line Hospitals IPO Assessment – Financials

If we have a look at the financials of Jupiter Life Line Hospitals we discover out that their belongings have elevated from ₹788.91 crores in March 2021 to ₹985.53 crores in March 2023. 

Their revenues additionally comply with an analogous development, practically doubling from ₹490.27 crores in March 2021 to ₹902.96 crores in March 2023. Whereas the corporate confronted a web lack of ₹2.30 crores, it reprised itself within the following years and reported a web revenue of ₹72.91 crores in FY23. The earnings reported in FY23 had been at a margin of 8.07% on its income.

By way of return ratios, it has a ROE of 20.03% and a RoCE of 20.94% as of FY23. These ratios counsel a superb return on shareholders’ capital and a superb use of firm assets.

Monetary Metrics 

Rivals of the Firm

The desk picture will provide you with an inventory of the corporate’s listed friends together with its income and affected person particulars:

Strengths of the Firm

• The corporate has superior ranges of hospitals that are extremely specialised and never extensively accessible, situated within the populated micro markets within the western area of India
• Every of the corporate’s three hospitals is a full-service hospital, working on an ‘all-hub-no-spoke’ mannequin the place every hospital is unbiased, individually well-equipped to serve the healthcare wants of the sufferers, proper from diagnostics to surgical procedure and rehabilitation.
• The corporate attracts and retains expert and skilled healthcare professionals which helps it keep its normal of high quality healthcare companies.
• The corporate’s administration together with the founder has good expertise within the discipline which helps them keep its operational and administrative effectivity.

Weaknesses of the Firm

• Not having the ability to appeal to or maintain healthcare professionals can significantly have an effect on an organization’s operations.
• The corporate operates in a extremely regulated trade. Any regulatory modifications or a failure to adjust to any rules can adversely have an effect on its enterprise.
• The corporate has excessive bills in relation to medical tools prices, manpower prices, infrastructure upkeep and restore prices, ancillary objects and prescription drugs. The lack to achieve these at an inexpensive value can impression its profitability.
• The corporate has sure public curiosity litigations in relation to the land on the place Thane Hospital is located. Proceedings in opposition to the corporate’s favour can adversely impression its enterprise.
• The corporate’s reasonably priced healthcare is dependent upon affected person quantity, occupancy charges, venture value administration, and capital effectivity. Any improve in such prices might adversely have an effect on its enterprise, monetary situation and outcomes of operations.

Jupiter Life Line Hospitals IPO Assessment – GMP

The shares of Jupiter Life Line Hospitals traded at a premium of 29.66% within the gray market on September fifth, 2023. The shares tarded at Rs 953. This offers it a premium of Rs 218 per share over the cap value of Rs 735.

Key IPO Info

Promoters: Dr. Ajay Thakker, Dr. Ankit Thakker and Western Medical Options Llp

Ebook Operating Lead Supervisor: ICICI Securities Restricted, Nuvama Wealth Administration Restricted, JM Monetary Restricted.

Registrar to the Provide: KFin Applied sciences Restricted

The Goal of the Difficulty

The web proceeds from this challenge can be utilized for the next functions:

• Full or half compensation/prepayment of sure borrowings availed by the corporate and Materials Subsidiary.
• Basic company functions.

In Closing

On this article, we regarded on the particulars of Jupiter Life Line Hospitals. Via this text, we are able to conclude that although the corporate operates in restricted areas, it has delivered good outcomes through the current monetary years. Though, as traders, it’s our duty to verify that the corporate’s efficiency will constantly improve sooner or later

What do you suppose the longer term holds for the corporate? Are you making use of for the IPO? Tell us within the feedback beneath.

Written By Aaron Vas

By using the inventory screener, inventory heatmap, portfolio backtesting, and inventory evaluate device on the Commerce Brains portal, traders achieve entry to complete instruments that allow them to establish the most effective shares additionally get up to date with inventory market information, and make well-informed funding choices.